CUSIP 02043Q107COMALNYQ4 2025
39 filings · latest Nov 5, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Capital World Investors | 16.30M | $6.48B |
| 2 | Fmr LLC | 15.90M | $6.32B |
| 3 | Vanguard Group Inc | 13.55M | $5.39B |
| 4 | Blackrock, Inc. | 10.40M | $4.14B |
| 5 | Capital Research Global Investors | 6.78M | $2.70B |
| 6 | Jpmorgan Chase & Co | 4.72M | $1.88B |
| 7 | State Street Corp | 3.23M | $1.28B |
| 8 | Geode Capital Management, LLC | 2.65M | $1.06B |
| 9 | Baillie Gifford & Co |
| 4 | Nov 12, 2024 | Fmr LLC | 13G/A | 11.5% | — | SEC |
| 5 | Nov 8, 2024 | Wellington Management Group LLP | 13G/A | 3.9% | 5.02M | SEC |
| 6 | Aug 12, 2024 | Fmr LLC | 13G/A | 10.5% | — | SEC |
| 7 | Jul 5, 2024 | Baillie Gifford & Co | 13G/A | 4.8% | 6.03M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.5% | 11.94M | SEC |
| 9 | Feb 9, 2024 | Capital World Investors | 13G/A | 13.1% | 16.40M | SEC |
| 10 | Feb 9, 2024 | Wellington Management Group LLP | 13G/A | 5.8% | 7.25M | SEC |
See the full Schedule 13D/13G history for Alnylam Pharmaceuticals Inc.
Unlock full history| 2.60M |
| $1.03B |
| 10 | Norges Bank | 2.25M | $895.82M |